NASDAQ : EXOZ
eXoZymes, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 4.13 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 38.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Details
| Name | eXoZymes, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 32 |
| Founded | 2014 |
| Ipo Date | 2024-11-13 |
| Ceo | Michael Heltzen |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 8.00 |
| Isin | US4618741098 |
| Cusip | 461874109 |
| Cik | 0002010788 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Michael Heltzen | President and Chief Executive Officer |
| Dr. Tyler Korman Ph.D. | Co-Founder and Chief Scientific Officer |
| Dr. Paul Opgenorth Ph.D. | Co-Founder and Vice President of Development |
| James U. Bowie Ph.D. | Founder and Independent Director |
| Fouad Nawaz | Vice President of Finance |
| Damien A. Perriman | Chief Commercial Officer |
| Lasse H. Gorlitz | Vice President of Communications |
| Michael Burns | Executive Vice President of Energy Transition |
| Amy Lunzer | Chief of Staff |
Contact
| Address | 750 Royal Oaks Drive, Suite 106, Monrovia, California 91016, United States |
| Phone | 626 415 1488 |
| Website | https://www.exozymes.com |